LENALIDOMIDE | LENALIDOMIDE | ATC L04AX04
ANTINEOPLASTIC THALIDOMIDE ANALOG POSSESSES IMMUNOMODULATORY, ANTIANGIOGENIC, AND ANTINEOPLASTIC PROPERTIES TARGET NOT KNOWN TREATMENT OF MULTIPLE MYELOMA (MM) | ORAL | Tmax 3.25 HOUR PPB 30 PERCENT HT 3 HOUR SOLUBILITY SOLUBLE IN ORGANIC SOLVENT/WATER MIXTURES | | PROTEIN CEREBLON Q96SW2 PROTEIN CEREBLON HOMO SAPIENS UNCLASSIFIED | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |